Hiroya Kobayashi Selected Research

Hiroya Kobayashi Research Topics

Disease

45	Neoplasms (Cancer) 02/2024 - 03/2002
10	Squamous Cell Carcinoma of Head and Neck 02/2024 - 09/2014
9	Lymphoma (Lymphomas) 07/2023 - 10/2004
6	Bites and Stings (Sting) 01/2023 - 06/2017
6	T-Cell Lymphoma (Lymphoma, T Cell) 02/2015 - 10/2004
5	Inflammation (Inflammations) 12/2023 - 04/2003
5	Breast Neoplasms (Breast Cancer) 11/2021 - 05/2005
5	Melanoma (Melanoma, Malignant) 06/2017 - 06/2007
4	Leukemia 07/2021 - 12/2005
3	Head and Neck Neoplasms (Head and Neck Cancer) 02/2024 - 12/2021
3	Colonic Neoplasms (Colon Cancer) 08/2022 - 03/2016
3	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 04/2008
3	Carcinoma (Carcinomatosis) 11/2015 - 10/2002
3	T-Cell Leukemia (Leukemia, T Cell) 12/2012 - 10/2004
3	Infections 03/2009 - 10/2006
3	Prostatic Neoplasms (Prostate Cancer) 06/2007 - 11/2003
2	Bone Resorption 03/2023 - 06/2020
2	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 06/2020
2	Neoplasm Metastasis (Metastasis) 08/2022 - 06/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 06/2017
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2012 - 10/2004
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2010 - 05/2010
1	Nasopharyngeal Carcinoma 01/2024
1	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 04/2023
1	Cerebral Small Vessel Diseases 04/2023
1	Periodontitis 03/2023
1	Pain (Aches) 08/2022
1	Hypoxia (Hypoxemia) 08/2022
1	Carcinogenesis 08/2022
1	Thrombocytopenia (Thrombopenia) 06/2022
1	Hemorrhage 06/2022
1	Megaloblastic Anemia 06/2022
1	Hereditary Folate Malabsorption 06/2022
1	Multiple Organ Failure (MODS) 06/2022
1	Atrophy 09/2021

Drug/Important Bio-Agent (IBA)

28	Peptides (Polypeptides)IBA 02/2024 - 10/2002
28	AntigensIBA 02/2024 - 03/2002
23	EpitopesIBA 02/2024 - 10/2002
13	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2002
11	VaccinesIBA 02/2023 - 03/2002
7	LigandsIBA 07/2023 - 02/2015
7	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2021 - 10/2004
6	HLA-DR Antigens (HLA-DR)IBA 08/2023 - 09/2014
6	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023 - 06/2017
4	Protein Subunit VaccinesIBA 02/2024 - 10/2006
4	InterferonsIBA 02/2023 - 01/2018
4	Membrane Proteins (Integral Membrane Proteins)IBA 05/2010 - 10/2006
4	Messenger RNA (mRNA)IBA 03/2009 - 04/2004
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2016
3	Immune Checkpoint InhibitorsIBA 08/2023 - 01/2017
3	CytokinesIBA 03/2023 - 09/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 02/2023 - 06/2007
3	Neoplasm Antigens (Tumor Antigens)IBA 12/2021 - 10/2002
3	Monoclonal AntibodiesIBA 08/2021 - 04/2003
3	Interferon Type IIBA 08/2021 - 06/2017
3	ChemokinesIBA 06/2017 - 06/2015
3	HLA-DR15 antigenIBA 12/2012 - 10/2004
2	terreinIBA 03/2023 - 06/2020
2	Mitogen-Activated Protein KinasesIBA 02/2023 - 01/2022
2	Granzymes (Granzyme)IBA 02/2023 - 12/2021
2	Dinoprostone (PGE2)FDA Link 01/2023 - 09/2014
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2023 - 09/2014
2	Cancer VaccinesIBA 08/2022 - 12/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 06/2016
2	B7-H1 AntigenIBA 01/2019 - 07/2017
2	Histocompatibility Antigens Class IIIBA 05/2014 - 07/2006
2	HLA-DR53IBA 12/2012 - 05/2005
2	Complementary DNA (cDNA)IBA 12/2007 - 12/2005
2	AutoantigensIBA 06/2006 - 10/2004
2	HLA-DR9 antigenIBA 05/2005 - 10/2004
2	Carcinoembryonic AntigenIBA 04/2004 - 10/2002
1	Gemcitabine FDA Link 08/2023
1	Brachyury protein (Brachyury)IBA 08/2023
1	Serine (L-Serine)FDA Link 04/2023
1	Peptide Hydrolases (Proteases)FDA Link 04/2023
1	Small Interfering RNA (siRNA)IBA 02/2023
1	Celecoxib (Celebrex)FDA Link 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Neurokinin AIBA 08/2022
1	Double-Stranded RNA (RNA, Double Stranded)IBA 08/2022
1	Poly I-CIBA 08/2022
1	TachykininsIBA 08/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2022
1	Mitogen-Activated Protein Kinase 3IBA 08/2022
1	Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA 08/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 06/2022
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021
1	Combined VaccinesIBA 12/2021
1	nutlin 3IBA 12/2021
1	MHC class II transactivator proteinIBA 12/2021
1	CollagenIBA 09/2021
1	olmesartanIBA 09/2021
1	Angiotensin Receptor AntagonistsIBA 09/2021

Therapy/Procedure

34	Immunotherapy 02/2024 - 10/2002
16	Therapeutics 08/2023 - 04/2004
2	Drug Therapy (Chemotherapy) 01/2018 - 10/2004
1	Ligation 03/2023
1	Immunomodulation 01/2022